Brigitte buys FRX 94.97: Forest Laboratories Announces Intention to Continue Marketing Both NAMENDA® TABLETS and Once-Daily NAMENDA XR® Into the Fall o ...
NEW YORK, Jun 10, 2014 (BUSINESS WIRE) -- Forest Laboratories, Inc. (NYSE:FRX) , a leading, fully integrated, specialty pharmaceutical company, today announced that it intends to continue to market both its NAMENDA® (memantine HCl) 5 mg and 10 mg tablets ... ...
32 people liked this
0 Comments:
Post a Comment
Subscribe to Post Comments [Atom]
<< Home